We are live on
!
Find out more
ICM
Islay Capital Management Portfolio holdings
AUM
$197M
1-Year Est. Return
19.56%
This Fund
S&P 500
This Quarter
Est. Return
+5.91%
1 Year Est. Return
+19.56%
3 Year Est. Return
+65.19%
5 Year Est. Return
+82.58%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$2.36M
(+1.9%)
Cap. Flow
-$4.08M
Cap. Flow
% of AUM
-3.3%
Top 10 Holdings %
Top 10 Hldgs %
43.44%
Holding
324
New
50
Increased
34
Reduced
80
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$1.95M |
| 2 |
Johnson & Johnson
JNJ
|
+$705K |
| 3 |
Fidelity Nasdaq Composite Index ETF
ONEQ
|
+$619K |
| 4 |
IFLN
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
|
+$376K |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$240K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.83M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.15M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.03M |
| 4 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$791K |
| 5 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$621K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.81% |
| 2 | Financials | 6.06% |
| 3 | Healthcare | 4.69% |
| 4 | Consumer Discretionary | 3.68% |
| 5 | Consumer Staples | 3.48% |
Similar funds
RC
ECP
GL
IMC
OCM
SWM
SCM
PCMM
Islay Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Islay Capital Management held 324 positions worth $124M, up 1.9% from $121M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Islay Capital Management withdrew a net $4.08M in Q2 2021, closing 42 positions and reducing 80 holdings. Its most notable exit was Humana, an estimated $273K position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 6.8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Islay Capital Management opened a new position in Apellis Pharmaceuticals worth $167K.
- Islay Capital Management's largest Q2 2021 buy was Apellis Pharmaceuticals: 2,648 shares worth $167K.
- Islay Capital Management added most to Invesco S&P 500 Equal Weight Technology ETF in Q2 2021, an estimated $1.95M increase.
- Islay Capital Management's biggest Q2 2021 reduction was Schwab US Dividend Equity ETF, cutting an estimated $1.83M.
- Islay Capital Management fully exited Humana in Q2 2021, selling an estimated $273K.
- Islay Capital Management's ten largest holdings make up 43% of its $124M portfolio in Q2 2021.
- Islay Capital Management opened 50 new positions and closed 42 in Q2 2021.
- Islay Capital Management's portfolio value rose 1.9% quarter-over-quarter to $124M.
Based on Islay Capital Management's 13F filing for Q2 2021, filed 2 Aug 2021.